Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-12-31 Sale | 2025-12-31 5:23 pm | Kymera Therapeutics Inc. | KYMR | Mainolfi Nello Chief Executive Officer | 30,000 | $78.06 | $2,341,939 | 938,636 (Direct) | View |
| 2025-12-17 Sale | 2025-12-17 6:07 pm | Kymera Therapeutics Inc. | KYMR | Esposito Pamela Director | 27,563 | $82.16 | $2,264,480 | 20,500 (Direct) | View |
| 2025-12-10 Sale | 2025-12-12 6:37 pm | Kymera Therapeutics Inc. | KYMR | Booth Bruce Director | 236,588 | $91.72 | $21,699,044 | 685,393 (Indirect) | View |
| 2025-12-11 Purchase | 2025-12-11 4:19 pm | Kymera Therapeutics Inc. | KYMR | BAKER BROS. ADVISORS LP 667 L.P. Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP BAKER FELIX BAKER JULIAN Director 10% Owner | 2,005,813 | $86 | $172,499,918 | 7,955,916 (Indirect) | View |
| 2025-12-08 Sale | 2025-12-08 6:09 pm | Kymera Therapeutics Inc. | KYMR | Albers Jeffrey W. Director | 5,000 | $89.76 | $448,823 | 7,000 (Direct) | View |
| 2025-12-08 Sale | 2025-12-08 6:09 pm | Kymera Therapeutics Inc. | KYMR | Mainolfi Nello Chief Executive Officer | 100,000 | $89.17 | $8,917,000 | 966,041 (Direct) | View |
| 2025-12-08 Sale | 2025-12-08 6:09 pm | Kymera Therapeutics Inc. | KYMR | Gollob Jared Chief Medical Officer | 49,307 | $88.67 | $4,371,833 | 144,075 (Direct) | View |
| 2025-10-29 Sale | 2025-10-29 5:19 pm | Kymera Therapeutics Inc. | KYMR | Mainolfi Nello Chief Executive Officer | 30,000 | $60.99 | $1,829,737 | 1,066,041 (Direct) | View |
| 2025-10-15 Sale | 2025-10-15 5:28 pm | Kymera Therapeutics Inc. | KYMR | Gollob Jared Chief Medical Officer | 59,576 | $61.42 | $3,659,254 | 109,992 (Direct) | View |
| 2025-10-13 Sale | 2025-10-14 5:11 pm | Kymera Therapeutics Inc. | KYMR | Gollob Jared Chief Medical Officer | 3,114 | $60 | $186,840 | 169,568 (Direct) | View |
| 2025-10-13 Sale | 2025-10-14 07:55 am | Kymera Therapeutics Inc. | KYMR | Albers Jeffrey W. Director | 5,000 | $59.19 | $295,949 | 0 (Direct) | View |
| 2025-09-17 Sale | 2025-09-17 5:16 pm | Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer | 79,220 | $50 | $3,961,380 | 255,062 (Direct) | View |
| 2025-09-16 Sale | 2025-09-16 4:11 pm | Kymera Therapeutics Inc. | KYMR | Mainolfi Nello Chief Executive Officer | 30,000 | $49 | $1,470,000 | 1,096,041 (Direct) | View |
| 2025-06-30 Purchase | 2025-07-01 6:41 pm | Kymera Therapeutics Inc. | KYMR | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N See Remarks and Footnotes | 317,167 | $44 | $13,955,348 | 1,806,904 (Indirect Direct) | View |
| 2025-06-30 Purchase | 2025-06-30 8:15 pm | Kymera Therapeutics Inc. | KYMR | BAKER BROS. ADVISORS LP 667 L.P. Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP BAKER FELIX BAKER JULIAN Director | 655,500 | $44 | $28,842,000 | 17,317,449 (Indirect) | View |
| 2025-06-11 Sale | 2025-06-11 4:47 pm | Kymera Therapeutics Inc. | KYMR | Ridloff Elena Director | 4,500 | $50 | $225,000 | 4,500 (Direct) | View |
| 2025-06-03 Sale | 2025-06-03 6:30 pm | Kymera Therapeutics Inc. | KYMR | Esposito Pamela Director | 5,000 | $49.04 | $245,186 | 24,127 (Direct) | View |
| 2025-06-03 Sale | 2025-06-03 6:30 pm | Kymera Therapeutics Inc. | KYMR | Ridloff Elena Director | 12,000 | $46.1 | $553,200 | 0 (Direct) | View |
| 2025-06-03 Sale | 2025-06-03 6:30 pm | Kymera Therapeutics Inc. | KYMR | Mainolfi Nello Chief Executive Officer | 30,000 | $49 | $1,470,000 | 1,126,041 (Direct) | View |
| 2025-06-03 Sale | 2025-06-03 6:30 pm | Kymera Therapeutics Inc. | KYMR | Albers Jeffrey W. Director | 6,349 | $49 | $311,101 | 5,000 (Direct) | View |
| 2025-05-23 Sale | 2025-05-23 4:30 pm | Kymera Therapeutics Inc. | KYMR | Chadwick Jeremy G Chief Operating Officer | 2,575 | $29.3 | $75,436 | 66,420 (Direct) | View |
| 2025-03-03 Sale | 2025-03-03 6:30 pm | Kymera Therapeutics Inc. | KYMR | Chiniara Ellen Chief Legal Officer | 2,241 | $30.45 | $68,239 | 135,085 (Direct) | View |
| 2025-03-03 Sale | 2025-03-03 6:30 pm | Kymera Therapeutics Inc. | KYMR | Chadwick Jeremy G Chief Operating Officer | 1,383 | $30.45 | $42,113 | 117,800 (Direct) | View |
| 2025-03-03 Sale | 2025-03-03 6:30 pm | Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer | 7,035 | $30.45 | $214,219 | 261,886 (Direct) | View |
| 2025-03-03 Sale | 2025-03-03 6:30 pm | Kymera Therapeutics Inc. | KYMR | Gollob Jared Chief Medical Officer | 5,740 | $30.45 | $174,786 | 180,000 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-12-31 Exercise | 2025-12-31 5:23 pm | N/A N/A | Kymera Therapeutics Inc. | KYMR | Mainolfi Nello Chief Executive Officer | 30,000 | $2.08 | 938,636 (Direct) | View |
| 2025-12-31 Exercise | 2025-12-31 5:23 pm | N/A 2029-11-13 | Kymera Therapeutics Inc. | KYMR | Mainolfi Nello Chief Executive Officer | 30,000 | $0 | 938,636 (Direct) | View |
| 2025-12-17 Exercise | 2025-12-17 6:07 pm | N/A N/A | Kymera Therapeutics Inc. | KYMR | Mainolfi Nello Chief Executive Officer | 2,595 | $38.53 | 935,582 (Direct) | View |
| 2025-12-17 Exercise | 2025-12-17 6:07 pm | N/A 2032-03-01 | Kymera Therapeutics Inc. | KYMR | Mainolfi Nello Chief Executive Officer | 2,595 | $0 | 935,582 (Direct) | View |
| 2025-12-17 Exercise | 2025-12-17 6:07 pm | N/A 2031-06-15 | Kymera Therapeutics Inc. | KYMR | Esposito Pamela Director | 27,563 | $0 | 20,500 (Direct) | View |
| 2025-12-17 Exercise | 2025-12-17 6:07 pm | N/A N/A | Kymera Therapeutics Inc. | KYMR | Esposito Pamela Director | 3,000 | $31.2 | 20,500 (Direct) | View |
| 2025-12-17 Exercise | 2025-12-17 6:07 pm | N/A N/A | Kymera Therapeutics Inc. | KYMR | Esposito Pamela Director | 12,563 | $49.1 | 20,500 (Direct) | View |
| 2025-12-17 Exercise | 2025-12-17 6:07 pm | N/A N/A | Kymera Therapeutics Inc. | KYMR | Esposito Pamela Director | 12,000 | $27.67 | 20,500 (Direct) | View |
| 2025-12-08 Exercise | 2025-12-08 6:09 pm | N/A 2032-06-15 | Kymera Therapeutics Inc. | KYMR | Albers Jeffrey W. Director | 5,000 | $0 | 7,000 (Direct) | View |
| 2025-12-08 Exercise | 2025-12-08 6:09 pm | N/A N/A | Kymera Therapeutics Inc. | KYMR | Albers Jeffrey W. Director | 5,000 | $14.18 | 7,000 (Direct) | View |
| 2025-12-08 Exercise | 2025-12-08 6:09 pm | N/A N/A | Kymera Therapeutics Inc. | KYMR | Mainolfi Nello Chief Executive Officer | 100,000 | $2.08 | 966,041 (Direct) | View |
| 2025-12-08 Exercise | 2025-12-08 6:09 pm | N/A 2029-11-13 | Kymera Therapeutics Inc. | KYMR | Mainolfi Nello Chief Executive Officer | 100,000 | $0 | 966,041 (Direct) | View |
| 2025-12-08 Exercise | 2025-12-08 6:09 pm | N/A N/A | Kymera Therapeutics Inc. | KYMR | Gollob Jared Chief Medical Officer | 49,307 | $5.33 | 144,075 (Direct) | View |
| 2025-12-08 Exercise | 2025-12-08 6:09 pm | N/A 2030-05-13 | Kymera Therapeutics Inc. | KYMR | Gollob Jared Chief Medical Officer | 49,307 | $0 | 144,075 (Direct) | View |
| 2025-10-29 Exercise | 2025-10-29 5:19 pm | N/A N/A | Kymera Therapeutics Inc. | KYMR | Mainolfi Nello Chief Executive Officer | 30,000 | $2.08 | 1,066,041 (Direct) | View |
| 2025-10-29 Exercise | 2025-10-29 5:19 pm | N/A 2029-11-13 | Kymera Therapeutics Inc. | KYMR | Mainolfi Nello Chief Executive Officer | 30,000 | $0 | 1,066,041 (Direct) | View |
| 2025-10-15 Exercise | 2025-10-15 5:28 pm | N/A N/A | Kymera Therapeutics Inc. | KYMR | Gollob Jared Chief Medical Officer | 22,210 | $2.08 | 109,992 (Direct) | View |
| 2025-10-15 Exercise | 2025-10-15 5:28 pm | N/A 2028-10-31 | Kymera Therapeutics Inc. | KYMR | Gollob Jared Chief Medical Officer | 51,209 | $0 | 109,992 (Direct) | View |
| 2025-10-15 Exercise | 2025-10-15 5:28 pm | N/A N/A | Kymera Therapeutics Inc. | KYMR | Gollob Jared Chief Medical Officer | 28,999 | $1.31 | 109,992 (Direct) | View |
| 2025-10-13 Exercise | 2025-10-14 5:11 pm | N/A N/A | Kymera Therapeutics Inc. | KYMR | Gollob Jared Chief Medical Officer | 673 | $2.08 | 169,568 (Direct) | View |
| 2025-10-13 Exercise | 2025-10-14 5:11 pm | N/A 2028-10-31 | Kymera Therapeutics Inc. | KYMR | Gollob Jared Chief Medical Officer | 1,473 | $0 | 169,568 (Direct) | View |
| 2025-10-13 Exercise | 2025-10-14 5:11 pm | N/A N/A | Kymera Therapeutics Inc. | KYMR | Gollob Jared Chief Medical Officer | 800 | $1.31 | 169,568 (Direct) | View |
| 2025-10-13 Exercise | 2025-10-14 07:55 am | N/A 2030-09-03 | Kymera Therapeutics Inc. | KYMR | Albers Jeffrey W. Director | 5,000 | $0 | 0 (Direct) | View |
| 2025-10-13 Exercise | 2025-10-14 07:55 am | N/A N/A | Kymera Therapeutics Inc. | KYMR | Albers Jeffrey W. Director | 5,000 | $10.34 | 0 (Direct) | View |
| 2025-09-17 Exercise | 2025-09-17 5:16 pm | N/A N/A | Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer | 79,220 | $2.08 | 255,062 (Direct) | View |
| 2025-09-17 Exercise | 2025-09-17 5:16 pm | N/A 2029-08-28 | Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer | 79,220 | $0 | 255,062 (Direct) | View |
| 2025-09-16 Exercise | 2025-09-16 4:11 pm | N/A N/A | Kymera Therapeutics Inc. | KYMR | Mainolfi Nello Chief Executive Officer | 30,000 | $2.08 | 1,096,041 (Direct) | View |
| 2025-09-16 Exercise | 2025-09-16 4:11 pm | N/A 2029-11-13 | Kymera Therapeutics Inc. | KYMR | Mainolfi Nello Chief Executive Officer | 30,000 | $0 | 1,096,041 (Direct) | View |
| 2025-09-03 Option Award | 2025-09-03 5:05 pm | N/A 2035-09-02 | Kymera Therapeutics Inc. | KYMR | Adams Brian Chief Legal Officer | 157,500 | $0 | 157,500 (Direct) | View |
| 2025-06-25 Option Award | 2025-07-01 6:41 pm | N/A 2035-06-24 | Kymera Therapeutics Inc. | KYMR | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N See Remarks and Footnotes | 16,000 | $0 | 1,806,904 (Indirect) | View |
| 2025-06-25 Option Award | 2025-06-26 9:00 pm | N/A 2035-06-24 | Kymera Therapeutics Inc. | KYMR | BAKER BROS. ADVISORS LP 667 L.P. Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP BAKER FELIX BAKER JULIAN Director | 32,000 | $0 | 32,000 (Indirect) | View |
| 2025-06-25 Option Award | 2025-06-26 9:00 pm | N/A 2035-06-24 | Kymera Therapeutics Inc. | KYMR | Albers Jeffrey W. Director | 16,000 | $0 | 16,000 (Direct) | View |
| 2025-06-25 Option Award | 2025-06-26 9:00 pm | N/A 2035-06-24 | Kymera Therapeutics Inc. | KYMR | Hrustanovic Gorjan Director | 16,000 | $0 | 16,000 (Direct) | View |
| 2025-06-25 Option Award | 2025-06-26 9:00 pm | N/A 2035-06-24 | Kymera Therapeutics Inc. | KYMR | Esposito Pamela Director | 16,000 | $0 | 16,000 (Direct) | View |
| 2025-06-25 Option Award | 2025-06-26 9:00 pm | N/A 2035-06-24 | Kymera Therapeutics Inc. | KYMR | MARAGANORE JOHN Director | 16,000 | $0 | 16,000 (Direct) | View |
| 2025-06-25 Option Award | 2025-06-26 9:00 pm | N/A 2035-06-24 | Kymera Therapeutics Inc. | KYMR | Booth Bruce Director | 16,000 | $0 | 16,000 (Direct) | View |
| 2025-06-25 Option Award | 2025-06-26 9:00 pm | N/A 2035-06-24 | Kymera Therapeutics Inc. | KYMR | Sandor Victor Director | 16,000 | $0 | 16,000 (Direct) | View |
| 2025-06-25 Option Award | 2025-06-26 9:00 pm | N/A 2035-06-24 | Kymera Therapeutics Inc. | KYMR | Ridloff Elena Director | 16,000 | $0 | 16,000 (Direct) | View |
| 2025-06-11 Exercise | 2025-06-11 4:47 pm | N/A N/A | Kymera Therapeutics Inc. | KYMR | Ridloff Elena Director | 4,500 | $20.29 | 4,500 (Direct) | View |
| 2025-06-11 Exercise | 2025-06-11 4:47 pm | N/A 2032-06-29 | Kymera Therapeutics Inc. | KYMR | Ridloff Elena Director | 4,500 | $0 | 4,500 (Direct) | View |
| 2025-06-03 Exercise | 2025-06-03 6:30 pm | N/A 2030-09-03 | Kymera Therapeutics Inc. | KYMR | Esposito Pamela Director | 5,000 | $0 | 24,127 (Direct) | View |
| 2025-06-03 Exercise | 2025-06-03 6:30 pm | N/A N/A | Kymera Therapeutics Inc. | KYMR | Esposito Pamela Director | 5,000 | $29.55 | 24,127 (Direct) | View |
| 2025-06-03 Exercise | 2025-06-03 6:30 pm | N/A 2033-06-15 | Kymera Therapeutics Inc. | KYMR | Ridloff Elena Director | 12,000 | $0 | 0 (Direct) | View |
| 2025-06-03 Exercise | 2025-06-03 6:30 pm | N/A N/A | Kymera Therapeutics Inc. | KYMR | Ridloff Elena Director | 12,000 | $27.67 | 0 (Direct) | View |
| 2025-06-03 Exercise | 2025-06-03 6:30 pm | N/A N/A | Kymera Therapeutics Inc. | KYMR | Mainolfi Nello Chief Executive Officer | 30,000 | $2.08 | 1,126,041 (Direct) | View |
| 2025-06-03 Exercise | 2025-06-03 6:30 pm | N/A 2029-11-13 | Kymera Therapeutics Inc. | KYMR | Mainolfi Nello Chief Executive Officer | 30,000 | $0 | 1,126,041 (Direct) | View |
| 2025-06-03 Exercise | 2025-06-03 6:30 pm | N/A 2030-09-03 | Kymera Therapeutics Inc. | KYMR | Albers Jeffrey W. Director | 6,349 | $0 | 5,000 (Direct) | View |
| 2025-06-03 Exercise | 2025-06-03 6:30 pm | N/A N/A | Kymera Therapeutics Inc. | KYMR | Albers Jeffrey W. Director | 6,349 | $10.34 | 5,000 (Direct) | View |
| 2025-04-08 Option Award | 2025-04-09 08:05 am | N/A 2035-04-07 | Kymera Therapeutics Inc. | KYMR | Goodman Noah Chief Business Officer | 150,000 | $0 | 150,081 (Direct) | View |
Ownership | 2025-04-09 08:00 am | N/A N/A | Kymera Therapeutics Inc. | KYMR | Goodman Noah Chief Business Officer | 0 | $0 | 81 (Direct) | View |
| 2025-03-31 Exercise | 2025-04-01 08:00 am | N/A N/A | Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer | 25,000 | $2.08 | 296,785 (Direct) | View |
| 2025-03-31 Exercise | 2025-04-01 08:00 am | N/A 2029-08-28 | Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer | 25,000 | $0 | 296,785 (Direct) | View |
| 2025-03-03 Option Award | 2025-03-03 6:30 pm | N/A 2035-03-02 | Kymera Therapeutics Inc. | KYMR | Chiniara Ellen Chief Legal Officer | 82,500 | $0 | 135,085 (Direct) | View |
| 2025-03-03 Option Award | 2025-03-03 6:30 pm | N/A 2035-03-02 | Kymera Therapeutics Inc. | KYMR | Chadwick Jeremy G Chief Operating Officer | 75,000 | $0 | 117,800 (Direct) | View |
| 2025-03-03 Option Award | 2025-03-03 6:30 pm | N/A 2035-03-02 | Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer | 90,000 | $0 | 261,886 (Direct) | View |
| 2025-03-03 Option Award | 2025-03-03 6:30 pm | N/A 2035-03-02 | Kymera Therapeutics Inc. | KYMR | Mainolfi Nello Chief Executive Officer | 365,000 | $0 | 365,000 (Direct) | View |
| 2025-03-03 Option Award | 2025-03-03 6:30 pm | N/A 2035-03-02 | Kymera Therapeutics Inc. | KYMR | Gollob Jared Chief Medical Officer | 90,000 | $0 | 180,000 (Direct) | View |